Surveillance des bactéries multi-résistantes dans les établissements de santé, Réseau BMR, vol.112, 2017. ,
Ubertragbare Resistenz gegen??ber Cefotaxim, Cefoxitin, Cefamandol und Cefuroxim in klinischen Isolaten von Klebsiella pneumoniae und Serratia marcescens, Infection, vol.147, issue.6, pp.315-322, 1983. ,
DOI : 10.1007/BF01641355
Recommandations relatives aux mesures à mettre en oeuvre pour prévenir l'émergence des entérobactéries BLSE et lutter contre leur dissémination. Fevrier Accessible à https, 2010. ,
CTX-M-1- and CTX-M-15-type ??-lactamases in clinical Escherichia coli isolates recovered from food-producing animals in France, International Journal of Antimicrobial Agents, vol.28, issue.5, pp.402-409, 2006. ,
DOI : 10.1016/j.ijantimicag.2006.08.016
URL : https://hal.archives-ouvertes.fr/hal-00420302
Community emergence of CTX-M type extended-spectrum ??-lactamases among urinary Escherichia coli from women, Journal of Antimicrobial Chemotherapy, vol.59, issue.1, pp.140-144, 2007. ,
DOI : 10.1093/jac/dkl483
Faecal carriage of extended-spectrum ??-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology, Journal of Antimicrobial Chemotherapy, vol.18, issue.1, pp.1142-1151, 2008. ,
DOI : 10.1017/S0950268806005917
, European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2016 Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) Stockholm: ECDC, 2017.
, Morbidité et mortalité des infections à bactéries multi-résistantes aux antibiotiques en France en 2012 Étude Burden BMR, rapport -Juin 2015. Saint-Maurice : Institut de veille sanitaire, 2015.
bloodstream infections, Future Microbiology, vol.39, issue.10, pp.1173-89, 2012. ,
DOI : 10.1093/cid/cir790
Community-onset extended-spectrum ??-lactamase (ESBL) producing Escherichia coli: Importance of international travel, Journal of Infection, vol.57, issue.6, pp.441-449, 2008. ,
DOI : 10.1016/j.jinf.2008.09.034
, Société de Pathologie Infectieuse de Langue Française Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires de l'adulte
, World Health Organization, éditeur Antimicrobial resistance: global report on surveillance World Health Organization, 2014.
Mortality and delay in effective therapy associated with extended-spectrum ??-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis, Journal of Antimicrobial Chemotherapy, vol.60, issue.5, pp.913-933, 2007. ,
DOI : 10.1093/jac/dkm318
, Third International Consensus Definitions for Sepsis and Septic Shock
, JAMA, vol.315, issue.8, pp.801-811, 2016.
Epidemiologic trends of sepsis in western countries, Annals of Translational Medicine, vol.4, issue.17, p.325, 2016. ,
DOI : 10.21037/atm.2016.08.59
The Epidemiology of Sepsis in the United States from 1979 through 2000, New England Journal of Medicine, vol.348, issue.16, pp.1546-54, 2000. ,
DOI : 10.1056/NEJMoa022139
The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study, Critical Care, vol.17, issue.2, p.65, 2013. ,
DOI : 10.1186/cc12598
URL : https://hal.archives-ouvertes.fr/inserm-00873494
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock, New England Journal of Medicine, vol.345, issue.19, pp.1368-77, 2001. ,
DOI : 10.1056/NEJMoa010307
,
, Critères de SEPSIS-3 aux urgences : étude prospective internationale de validation du qSOFA (the SCREEN study) Médecine et Maladies Infectieuses, p.7, 2017.
,
, Stratégies de réduction de l'utilisation des antibiotiques à visée curative en réanimation (adulte et pédiatrique), Réanimation, vol.23, issue.5, pp.558-82, 2014.
, The Journal of Infectious Diseases, vol.184, issue.1, pp.66-72, 2001.
DOI : 10.1086/320992
in travellers, Journal of Antimicrobial Chemotherapy, vol.67, issue.12, pp.3548-55, 2016. ,
DOI : 10.1111/1469-0691.12099
Non-invasive erythromycin-resistant pneumococcal isolates are more often non-susceptible to more antimicrobial agents than invasive isolates, International Journal of Antimicrobial Agents, vol.35, issue.1, pp.72-77, 2010. ,
DOI : 10.1016/j.ijantimicag.2009.09.006
URL : https://hal.archives-ouvertes.fr/hal-00556365
Virulence determinant and extended spectrum beta-lactamase production in Klebsiella pneumoniae isolated from a tertiary care hospital, South India, J Lab Physicians, vol.10, issue.242, pp.155-61, 2018. ,
Extended-Spectrum ??-Lactamase Production Is Associated with an Increase in Cell Invasion and Expression of Fimbrial Adhesins in Klebsiella pneumoniae, Antimicrobial Agents and Chemotherapy, vol.52, issue.9, pp.3029-3063, 2008. ,
DOI : 10.1128/AAC.00010-08
Comparison of extended spectrum ??????-lactamases-producing Escherichia coli with non-ESBLsproducing E.coli: drug-resistance and virulence, World Journal of Emergency Medicine, vol.3, issue.3, pp.208-220, 2012. ,
DOI : 10.5847/wjem.j.issn.1920-8642.2012.03.009
Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing <i>Escherichia coli</i> at a Tertiary Hospital, Internal Medicine, vol.56, issue.14, pp.1807-1822, 2017. ,
DOI : 10.2169/internalmedicine.56.7702
Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum ??-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis, Journal of Antimicrobial Chemotherapy, vol.45, issue.6, pp.1311-1331, 2012. ,
DOI : 10.1086/522799
Outcome of Bacteremia Caused by Extended-Spectrum ??-Lactamase???Producing Enterobacteriaceae After Solid Organ Transplantation, Transplantation Proceedings, vol.46, issue.6, pp.1753-1759, 2014. ,
DOI : 10.1016/j.transproceed.2014.05.003
Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum ??-lactamase-producing Escherichia coli, International Journal of Antimicrobial Agents, vol.36, issue.3, pp.284-291, 2010. ,
DOI : 10.1016/j.ijantimicag.2010.05.009
Risk factors for infection and treatment outcome of extended-spectrum ??-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy, Annals of Hematology, vol.50, issue.Suppl 3, pp.115-136, 2012. ,
DOI : 10.1128/AAC.50.2.498-504.2006
National Multicenter Study of Predictors and Outcomes of Bacteremia upon Hospital Admission Caused by Enterobacteriaceae Producing Extended-Spectrum ??-Lactamases, Antimicrobial Agents and Chemotherapy, vol.54, issue.12, pp.5099-104, 2010. ,
DOI : 10.1128/AAC.00565-10
Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia, Journal of Antimicrobial Chemotherapy, vol.60, issue.6, pp.1355-60, 2007. ,
DOI : 10.1093/jac/dkm378
,
, Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia, Eur J Clin Microbiol Infect Dis, vol.31, issue.9, pp.2191-2196, 2012.
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients, JAMA, vol.286, issue.14, pp.1754-1762, 2001. ,
DOI : 10.1001/jama.286.14.1754
Indices de comorbidité : revue de la littérature et application aux études des populations « âgées, Rev Epidemiol Sante Publique, vol.49, issue.3, pp.287-98, 2001. ,
The Surviving Sepsis Campaign???s Revised Sepsis Bundles, Current Infectious Disease Reports, vol.182, issue.6, pp.385-93, 2013. ,
DOI : 10.1164/rccm.200912-1918OC
URL : http://europepmc.org/articles/pmc3864669?pdf=render
,
, Am J Emerg Med, vol.30, issue.8, pp.1447-56, 2012.
Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-??-Lactamase-Producing Enterobacteriaceae: Importance of Inadequate Initial Antimicrobial Treatment, Antimicrobial Agents and Chemotherapy, vol.51, issue.6, pp.1987-94, 2007. ,
DOI : 10.1128/AAC.01509-06
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study, BMC Infectious Diseases, vol.165, issue.Suppl 2, p.245, 2012. ,
DOI : 10.1001/archinte.165.12.1375
??-Lactam/??-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum ??-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts, Clinical Infectious Diseases, vol.44, issue.3, pp.167-74, 2012. ,
DOI : 10.1086/510590
Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum ??-Lactamase Bacteremia, Clinical Infectious Diseases, vol.54, issue.7, pp.1319-1344, 2015. ,
DOI : 10.1128/AAC.01808-09
URL : https://academic.oup.com/cid/article-pdf/60/9/1319/1129246/civ003.pdf
Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis, JAMA, vol.316, issue.17, pp.3161775-85, 2016. ,
DOI : 10.1001/jama.2016.14799